Recent advances in the biology and chemistry of the flavaglines.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2012-03-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2011.10.048PMID 22071525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of aneuploidy-selective antiproliferation compounds.

  2011cited by this paper
• Novel flavaglines displaying improved cytotoxicity.

  2011cited by this paper
• Resistance to the Translation Initiation Inhibitor Silvestrol is Mediated by ABCB1/P-Glycoprotein Overexpression in Acute Lymphoblastic Leukemia Cells

  2011cited by this paper
• Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression

  2011cited by this paper
• Rapamycin Protects against Neuron Death in In Vitro andIn Vivo Models of Parkinson's Disease

  2010cited by this paper
• Biomimetic photocycloaddition of 3-hydroxyflavones: synthesis and evaluation of rocaglate derivatives as inhibitors of eukaryotic translation.

  2010cited by this paper
• Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells.

  2010cited by this paper
• Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata.

  2010cited by this paper
• Constituents of Amoora cucullata with TRAIL resistance-overcoming activity.

  2010cited by this paper
• Rocaglamide sensitizes leukemic T cells to activation-induced cell death by differential regulation of CD95L and c-FLIP expression

  2009cited by this paper
• Antitumor Activity and Mechanism of Action of the Cyclopenta[b]benzofuran, Silvestrol

  2009cited by this paper
• Next generation oncology drug development: opportunities and challenges

  2009cited by this paper
• Histone deacetylase inhibitors and neurodegenerative disorders: holding the promise.

  2009cited by this paper
• The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.

  2009cited by this paper
• Synthetic analogue of rocaglaol displays a potent and selective cytotoxicity in cancer cells: involvement of apoptosis inducing factor and caspase-12.

  2009cited by this paper
• Nazarov cyclization initiated by peracid oxidation: the total synthesis of (+/-)-rocaglamide.

  2009cited by this paper
• Total synthesis of the potent anticancer Aglaia metabolites (-)-silvestrol and (-)-episilvestrol and the active analogue (-)-4'-desmethoxyepisilvestrol.

  2009cited by this paper
• Histone deacetylase inhibitors: possible implications for neurodegenerative disorders

  2008cited by this paper
• Total Synthesis and Biological Activity of (±)‐Rocaglamide and Its 2,3‐Di‐epi Analogue

  2008cited by this paper
• Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model.

  2008cited by this paper
• Stereoselective synthesis of the rocaglamide skeleton via a silyl vinylketene formation/[4 + 1] annulation sequence.

  2008cited by this paper
• Enantioselective synthesis of the complex rocaglate (-)-silvestrol.

  2007cited by this paper
• Total synthesis of (-)-episilvestrol and (-)-silvestrol.

  2007cited by this paper
• Silvestrol, a potential anticancer rocaglate derivative from Aglaia foveolata, induces apoptosis in LNCaP cells through the mitochondrial/apoptosome pathway without activation of executioner caspase-3 or -7.

  2007cited by this paper
• The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen‐activated protein kinase activities

  2007cited by this paper
• Potent cytotoxic rocaglamide derivatives from the fruits of Amoora cucullata.

  2006cited by this paper
• Potential of cyclopenta[b]benzofurans from Aglaia species in cancer chemotherapy.

  2006cited by this paper
• Rocaglaol induces apoptosis and cell cycle arrest in LNCaP cells.

  2006cited by this paper
• Apoptosis in retinal degeneration involves cross-talk between apoptosis-inducing factor (AIF) and caspase-12 and is blocked by calpain inhibitors

  2006cited by this paper
• Using small molecules to overcome drug resistance induced by a viral oncogene.

  2006cited by this paper
• A Central Strategy for Converting Natural Products into Fluorescent Probes

  2006cited by this paper
• Silvestrol regulates G2/M checkpoint genes independent of p53 activity.

  2006cited by this paper
• Cross-talk between two apoptotic pathways activated by endoplasmic reticulum stress: differential contribution of caspase-12 and AIF

  2006cited by this paper
• Activity-guided isolation of cytotoxic constituents from the bark of Aglaia crassinervia collected in Indonesia.

  2006cited by this paper
• Cytotoxic flavaglines and bisamides from Aglaia edulis.

  2006cited by this paper
• Rapamycin pre-treatment protects against apoptosis.

  2006cited by this paper
• Stereospecific synthesis of (+/-)-1,2-anhydro methyl rocaglate.

  2005cited by this paper
• Cell Death Independent of Caspases: A Review

  2005cited by this paper
• A Synthetic Derivative of the Natural Product Rocaglaol Is a Potent Inhibitor of Cytokine-Mediated Signaling and Shows Neuroprotective Activity in Vitro and in Animal Models of Parkinson's Disease and Traumatic Brain Injury

  2005cited by this paper
• Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.

  2004cited by this paper
• A biomimetic approach to the rocaglamides employing photogeneration of oxidopyryliums derived from 3-hydroxyflavones.

  2004cited by this paper
• Flavaglines: A group of efficient growth inhibitors block cell cycle progression and induce apoptosis in colorectal cancer cells

  2004cited by this paper
• Rocaglamide Derivatives Are Potent Inhibitors of NF-κB Activation in T-cells*

  2002cited by this paper
• Rocaglamide derivatives are potent inhibitors of NF-kappa B activation in T-cells.

  2002cited by this paper
• Chemistry and Biological Activity of Rocaglamide Derivatives and Related Compounds in Aglaia Species (Meliaceae)

  2001cited by this paper
• Total synthesis of (±)-rocaglamide and some aryl analogues

  2001cited by this paper
• Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaia elliptica.

  1998cited by this paper
• Synthesis of the novel anti-leukaemic tetrahydrocyclopenta[b]benzofuran, rocaglamide and related synthetic studies

  1992cited by this paper

• Synthesis of 2,3-Dihydrobenzofurans via a Photochemical Gold-Mediated Atom Transfer Radical Addition Reaction.

  2024cites this paper
• Silvestrol, a potent anticancer agent with unfavourable pharmacokinetics: Current knowledge on its pharmacological properties and future directions for the development of novel drugs.

  2024cites this paper
• Thiol-Triggered Tandem Dearomative Michael Addition/Intramolecular Henry Reaction of 2-Nitrobenzofurans: Access to Sulfur-Containing Polyheterocyclic Compounds.

  2024cites this paper
• Isolation and identification of allelochemicals and their activities and functions

  2024cites this paper
• Diastereoselective Synthesis of Dihydrobenzofuran-Fused Spiroindolizidines via Double-Dearomative [3 + 2] Cycloadditions.

  2022cites this paper
• Organocatalyzed asymmetric dearomative 1,3-dipolar cycloaddition of 2-nitrobenzofurans and N-2,2,2-trifluoroethylisatin ketimines.

  2022cites this paper
• The Flavagline Compound 1-(2-(dimethylamino)acetyl)-Rocaglaol Induces Apoptosis in K562 Cells by Regulating the PI3K/Akt/mTOR, JAK2/STAT3, and MAPK Pathways

  2022cites this paper
• Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae)

  2021cites this paper
• 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties.

  2021cites this paper
• Update on Phytochemical and Biological Studies on Rocaglate Derivatives from Aglaia Species

  2021cites this paper
• Synthesis of 2,3,4-Trisubstituted 2-Cyclopentenones via Sequential Functionalization of 2-Cyclopentenone.

  2021cites this paper
• Strategic Diastereoselective C1 Functionalization in the Aza-Rocaglamide Scaffold toward Natural Product-Inspired eIF4A Inhibitors.

  2020cites this paper
• Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA Helicase.

  2020cites this paper
• Facile synthesis of chiral [2,3]-fused hydrobenzofuran via asymmetric Cu(i)-catalyzed dearomative 1,3-dipolar cycloaddition.

  2019cites this paper
• Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects

  2019cites this paper
• Targeting Mitogen-Activated Protein Kinases by Natural Products: A Novel Therapeutic Approach for Inflammatory Bowel Diseases.

  2019cites this paper
• The synthetic flavagline FL3 spares normal human skin cells from its cytotoxic effect via an activation of Bad.

  2019cites this paper
• Enantioselective dearomative [3+2] cycloaddition of 2-nitrobenzofurans with aldehyde-derived Morita-Baylis-Hillman carbonates.

  2019cites this paper
• Intercepted Retro-Nazarov Reaction: Syntheses of Amidino-Rocaglate Derivatives and Their Biological Evaluation as eIF4A Inhibitors.

  2019cites this paper
• Amidino-Rocaglates: A Potent Class of eIF4A Inhibitors.

  2019cites this paper
• Structurally Modified Cyclopenta[b]benzofuran Analogues Isolated from Aglaia perviridis.

  2019cites this paper
• Chemical Synthesis Enables Structural Reengineering of Aglaroxin C Leading to Inhibition Bias for Hepatitis C Viral Infection.

  2018cites this paper
• The Search for Anticancer Agents from Tropical Plants.

  2018cites this paper
• Antiviral Agents Towards Chikungunya Virus: Structures, Syntheses, and Isolation from Natural Sources

  2017cites this paper
• Cytotoxic Rocaglate Derivatives from Leaves of Aglaia perviridis

  2016cites this paper
• Recent Advances in the Synthesis of Flavaglines, a Family of Potent Bioactive Natural Compounds Originating from Traditional Chinese Medicine

  2016cites this paper
• Synthesis of rocaglamide derivatives and evaluation of their Wnt signal inhibitory activities.

  2016cites this paper
• Résistances/sensibilisations aux anti-CD20 (rituximab) dans les lymphomes diffus à grandes cellules B (DLBCL)

  2016cites this paper
• Flavaglines Ameliorate Experimental Colitis and Protect Against Intestinal Epithelial Cell Apoptosis and Mitochondrial Dysfunction

  2016cites this paper
• The Protective Role of Phenolic Compounds Against Doxorubicin-induced Cardiotoxicity: A Comprehensive Review

  2016cites this paper
• Chinese herb derived-Rocaglamide A is a potent inhibitor of pancreatic cancer cells.

  2016cites this paper
• Synthesis of Aza-Rocaglates via ESIPT-Mediated (3+2) Photocycloaddition.

  2016cites this paper
• A Potent Phytotoxic Substance in Aglaia odorata Lour.

  2016cites this paper
• Cyclopenta[b]benzofuran and Secodammarane Derivatives from the Stems of Aglaia stellatopilosa.

  2016cites this paper
• Synthesis of 2,3-Dihydrobenzofurans via the Palladium Catalyzed Carboalkoxylation of 2-Allylphenols.

  2016cites this paper
• Ribonucleoprotein bodies are phased in.

  2016cites this paper
• Cytotoxic flavonol-diamide [3+2] adducts from the leaves of Aglaia odorata

  2015cites this paper
• Assessment of flavaglines as potential chikungunya virus entry inhibitors

  2015cites this paper
• Cycloisomerization of Conjugated Trienones and Isomeric 2H-Pyrans: Unified Strategy toward Cyclopenta[b]furans.

  2015cites this paper
• Bioactive Flavaglines: Synthesis and Pharmacology

  2015cites this paper
• The Literature of Heterocyclic Chemistry, Part XIII, 2012–2013

  2015cites this paper
• A Nucleotide Signature for Identification of Aglaiastellatopilosa Pannell

  2014cites this paper
• Remodeling Natural Products: Chemistry and Serine Hydrolase Activity of a Rocaglate-Derived β-Lactone

  2014cites this paper
• Simplified Silvestrol Analogues with Potent Cytotoxic Activity

  2014cites this paper
• Rocaglamide, silvestrol and structurally related bioactive compounds from Aglaia species.

  2014cites this paper
• An interrupted vinylogous iso-Nazarov reaction: cycloisomerization of conjugated trienones to cyclopenta[b]furan derivatives.

  2014cites this paper
• Expression of PHB2 in Rat Brain Cortex Following Traumatic Brain Injury

  2014cites this paper
• Bioactive flavaglines and other constituents isolated from Aglaia perviridis.

  2013cites this paper
• Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A.

  2013cites this paper
• Prohibitin Ligands in Cell Death and Survival: Mode of Action and Therapeutic Potential

  2013cites this paper
• Flavaglines as potent anticancer and cytoprotective agents.

  2012cites this paper
• Synthetic silvestrol analogues as potent and selective protein synthesis inhibitors.

  2012cites this paper
• N-[3a-(4-Bromophenyl)-8b-hydroxy-6,8-dimethoxy-3-phenyl-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-1-yl]formamide monohydrate

  2012cites this paper
• Enantioselective photocycloaddition of 3-hydroxyflavones: total syntheses and absolute configuration assignments of (+)-ponapensin and (+)-elliptifoline.

  2012cites this paper